Studies have shown that the PPARα agonist Fenofibrate can improve renal function by inhibiting the oxidative stress, inflammatory response, and apoptosis in diabetic nephropathy rats (Hou et al., 2010; Yaribeygi et al., 2018). This evidence concerns the gene PPARA and diabetic kidney disease.